Women with severe anaemia in pregnancy had around five times the odds of acute heart failure compared with women without anaemia, a large study in India has found. The research, led by Oxford Population Health and published in JAMA Cardiology on November 18, studied more than 1,600 women in India. It found that anaemia and iron deficiency were each linked to heart failure during pregnancy and after childbirth, even after other risk factors were taken into account.
Acute heart failure is a serious condition in which the heart suddenly cannot pump blood well enough to meet the body’s needs. Pregnancy places extra demands on the heart, and anaemia could precipitate heart failure in women with underlying heart disease. Heart failure in pregnancy can develop quickly, and cardiovascular disease is a leading cause of indirect maternal deaths in low- and middle-income countries. Until now there had been little evidence about the link between these conditions and heart failure in pregnant and postpartum women.
How the anaemia study was carried out
The researchers studied 532 women clinically diagnosed with acute heart failure during pregnancy or after childbirth, and compared them with 1,091 women with no known history or symptoms of heart failure. The women were recruited from 10 hospitals across four Indian states that form part of the Maternal and Perinatal Health Research Collaboration in India (MaatHRI), between February 2019 and November 2024. Blood samples were tested for haemoglobin, ferritin, transferrin saturation, soluble transferrin receptor and hepcidin. The research team adjusted for other factors, including hypertensive disorders of pregnancy, and the data were analysed from March 2025 to April 2026.
Moderate anaemia was linked to around 1.5 times higher odds of acute heart failure, with an adjusted odds ratio of 1.52. Severe anaemia carried around five times the odds, with an adjusted odds ratio of 5.06. Markers of iron deficiency were also linked to heart failure on their own: higher soluble transferrin receptor levels carried an adjusted odds ratio of 1.44, and the lowest hepcidin quintile carried an adjusted odds ratio of 2.65. The researchers also looked at transferrin saturation and hepcidin, two markers that show how the body stores and uses iron. The links held even after allowing for how low haemoglobin had fallen.
Why it matters for maternal health
Most of the women diagnosed with acute heart failure, 93 per cent, had no known history of heart disease. The links between anaemia, iron deficiency and heart failure were consistent in women with echocardiographic abnormalities and in those with peripartum cardiomyopathy, a form of heart failure around childbirth. Adding it to established risk factors improved the model’s ability to identify women at risk, raising the area under the curve from 78 per cent to 83 per cent.
Iron deficiency can exist without low haemoglobin, and the study found its markers were linked to heart failure even after allowing for haemoglobin levels. That suggests iron deficiency may matter for maternal heart health in its own right, rather than only through low haemoglobin. Iron deficiency remains widespread in low- and middle-income countries, and it is an important and potentially modifiable contributor to maternal health complications.
Professor Manisha Nair, who led the research at Oxford Population Health, said, “Our findings reinforce the importance of screening for anaemia and iron deficiency before pregnancy, and ensuring that women receive appropriate treatment.” She added, “Despite substantial national efforts to tackle anaemia in India, it remains a major challenge for maternal health. We need to continue strengthening prevention and treatment, while ensuring that guidelines for screening, preventing and managing heart problems during pregnancy take account of conditions that are particularly common in low- and middle-income countries.”
What anaemia screening could change
The authors say screening before pregnancy, and treatment where levels are low, could lower the risk of heart failure in pregnancy. India already runs national programmes to prevent and treat low haemoglobin in pregnant women, including iron and folic acid supplements. The study’s authors say guidelines for heart problems in pregnancy should reflect conditions that are common in low- and middle-income countries, so that women at risk are picked up earlier.
As an observational study, the research cannot establish that either condition causes acute heart failure. Further research is needed to determine whether preventing or treating these conditions can reduce the likelihood of heart failure during pregnancy and improve maternal outcomes. The study is the first large multicentre study to investigate the links between maternal iron status and acute heart failure during pregnancy and after childbirth in India.

